These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10375401

  • 21. Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1).
    Maeno K, Nakajima A, Conseil G, Rothnie A, Deeley RG, Cole SP.
    Drug Metab Dispos; 2009 Jul; 37(7):1411-20. PubMed ID: 19398503
    [Abstract] [Full Text] [Related]

  • 22. Functional role of the linker region in purified human P-glycoprotein.
    Sato T, Kodan A, Kimura Y, Ueda K, Nakatsu T, Kato H.
    FEBS J; 2009 Jul; 276(13):3504-16. PubMed ID: 19490125
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein.
    Esser L, Shukla S, Zhou F, Ambudkar SV, Xia D.
    Acta Crystallogr F Struct Biol Commun; 2016 Aug; 72(Pt 8):636-41. PubMed ID: 27487928
    [Abstract] [Full Text] [Related]

  • 25. Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.
    Booth-Genthe CL, Louie SW, Carlini EJ, Li B, Leake BF, Eisenhandler R, Hochman JH, Mei Q, Kim RB, Rushmore TH, Yamazaki M.
    J Pharmacol Toxicol Methods; 2006 Aug; 54(1):78-89. PubMed ID: 16545584
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
    Zhang DW, Gu HM, Vasa M, Muredda M, Cole SP, Deeley RG.
    Biochemistry; 2003 Aug 26; 42(33):9989-10000. PubMed ID: 12924948
    [Abstract] [Full Text] [Related]

  • 28. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.
    Druley TE, Stein WD, Roninson IB.
    Biochemistry; 2001 Apr 10; 40(14):4312-22. PubMed ID: 11284687
    [Abstract] [Full Text] [Related]

  • 29. High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells.
    Karlsson JE, Heddle C, Rozkov A, Rotticci-Mulder J, Tuvesson O, Hilgendorf C, Andersson TB.
    Drug Metab Dispos; 2010 Apr 10; 38(4):705-14. PubMed ID: 20071452
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
    Yousif S, Chaves C, Potin S, Margaill I, Scherrmann JM, Declèves X.
    J Neurochem; 2012 Nov 10; 123(4):491-503. PubMed ID: 22845665
    [Abstract] [Full Text] [Related]

  • 32. Cholesterol-dependent conformational changes of P-glycoprotein are detected by the 15D3 monoclonal antibody.
    Gutay-Tóth Z, Fenyvesi F, Bársony O, Szente L, Goda K, Szabó G, Bacsó Z.
    Biochim Biophys Acta; 2016 Mar 10; 1861(3):188-95. PubMed ID: 26704667
    [Abstract] [Full Text] [Related]

  • 33. Identification of putative steroid-binding sites in human ABCB1 and ABCG2.
    Mares-Sámano S, Badhan R, Penny J.
    Eur J Med Chem; 2009 Sep 10; 44(9):3601-11. PubMed ID: 19303670
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Identification of a sister gene to P-glycoprotein.
    Childs S, Yeh RL, Georges E, Ling V.
    Cancer Res; 1995 May 15; 55(10):2029-34. PubMed ID: 7538046
    [Abstract] [Full Text] [Related]

  • 38. P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin.
    Lagas JS, Sparidans RW, van Waterschoot RA, Wagenaar E, Beijnen JH, Schinkel AH.
    Antimicrob Agents Chemother; 2008 Mar 15; 52(3):1034-9. PubMed ID: 18195061
    [Abstract] [Full Text] [Related]

  • 39. Selection of phage-displayed peptides mimicking an extracellular epitope of human MDR1-P-glycoprotein.
    Poloni F, Palumbo S, Cianfriglia M, Felici F.
    Physiol Chem Phys Med NMR; 1995 Mar 15; 27(4):271-80. PubMed ID: 8768783
    [Abstract] [Full Text] [Related]

  • 40. Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance.
    Battisti RF, Zhong Y, Fang L, Gibbs S, Shen J, Nadas J, Zhang G, Sun D.
    Mol Pharm; 2007 Mar 15; 4(1):140-53. PubMed ID: 17274671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.